4.63
-0.22(-4.54%)
Currency In USD
Previous Close | 4.85 |
Open | 4.61 |
Day High | 4.77 |
Day Low | 4.45 |
52-Week High | 7.63 |
52-Week Low | 4.17 |
Volume | 2.33M |
Average Volume | 2.02M |
Market Cap | 1.41B |
PE | 46.3 |
EPS | 0.1 |
Moving Average 50 Days | 4.95 |
Moving Average 200 Days | 5.9 |
Change | -0.22 |
If you invested $1000 in MannKind Corporation (MNKD) 10 years ago, it would be worth $255.1 as of May 09, 2025 at a share price of $4.63. Whereas If you bought $1000 worth of MannKind Corporation (MNKD) shares 5 years ago, it would be worth $3,494.34 as of May 09, 2025 at a share price of $4.63.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025
GlobeNewswire Inc.
May 01, 2025 8:05 PM GMT
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that its first quarter 2025 financial results will be released before market open on May 8, 2025. MannKind will host
MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options
GlobeNewswire Inc.
Apr 07, 2025 4:30 PM GMT
No. 76 MannKind "Tired of Pricks? Livery Junco Hollinger Racing driver Conor Daly to power the No. 76 MannKind "Tired of Pricks?" Chevrolet at the 2025 Acura Grand Prix of Long Beach to raise awareness of diabetes and innovative treatment options
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
GlobeNewswire Inc.
Mar 10, 2025 10:05 AM GMT
Five presentations affirm positive outcomes utilizing inhaled insulinAn sNDA filing for Afrezza in pediatric population anticipated in 2025 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq